Download PDF
Dialyse aktuell 2019; 23(03): 118-123
DOI: 10.1055/a-0874-5340
Schwerpunkt | Nephrologie
© Georg Thieme Verlag Stuttgart · New York

Differenzialdiagnose des Bluthochdruckes

Ein aktueller Überblick
Severin Schricker
1   Allgemeine Innere Medizin und Nephrologie, Robert-Bosch-Krankenhaus, Stuttgart
› Author Affiliations
Further Information

Publication History

Publication Date:
17 April 2019 (online)

Also available at
    Permissions and Reprints

ZUSAMMENFASSUNG

Die arterielle Hypertonie betrifft etwa jeden dritten Menschen. Sie stellt einen der Hauptfaktoren kardiovaskulärer Morbidität und Mortalität dar. Neben der sehr häufigen multifaktoriellen und polygenen primären oder essenziellen Hypertonie existieren verschiedene Ursachen, welche teilweise kausale Behandlungsansätze erlauben und somit eine große prognostische Relevanz besitzen. Das pathophysiologische Verständnis und die Kenntnis möglicher Differenzialdiagnosen sind für einen rationellen Einsatz der Diagnostik unerlässlich. Der vorliegende Artikel fasst diese zusammen und stellt mögliche Vorgehensweisen zur Bewertung verschiedener Formen der sekundären Hypertonie dar.

 

  • Literatur

  • 1 Neuhauser H, Kuhnert R, Born S. 12-Monats-Prävalenz von Bluthochdruck in Deutschland JoHM. 2017: 2
    Google Scholar
  • 2 Neuhauser H, Adler C, Diederichs C. et al. Der Blutdruck in Deutschland ist gesunken, das Präventionspotenzial bleibt aber hoch. Epidemiologisches Bulletin 2015; 5: 33-36
    Google Scholar
  • 3 Aronow WS, Fleg JL, Pepine CJ. et al. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol 2011; 57: 2037-2114 doi:https://doi.org/10.1016/j.jacc.2011.01.008
    CrossrefPubMedGoogle Scholar
  • 4 Williams B, Mancia G, Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36: 1953-2041
    CrossrefPubMedGoogle Scholar
  • 5 Wallbach M, Koziolek M. Therapieresistente und-refraktäre arterielle Hypertonie. Internist (Berl) 2018; 59: 567-579
    CrossrefPubMedGoogle Scholar
  • 6 Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354: 2368-2374
    CrossrefPubMedGoogle Scholar
  • 7 Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen?. Eur Heart J 2014; 35: 1245-1254 doi:10.1093/eurheartj/eht534
    CrossrefPubMedGoogle Scholar
  • 8 Pickering TG, Hall JE, Appel LJ. et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111: 697-716 doi:10.1161/01.Cir.0000154900.76284.F6
    CrossrefPubMedGoogle Scholar
  • 9 Group SR. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103-2116
    CrossrefPubMedGoogle Scholar
  • 10 Messerli FH, Ventura HO, Amodeo C. Osler’s maneuver and pseudohypertension. N Engl J Med 1985; 312: 1548-1551 doi:10.1056/nejm198506133122405
    CrossrefPubMedGoogle Scholar
  • 11 Belmin J, Visintin JM, Salvatore R. et al. Osler’s maneuver: absence of usefulness for the detection of pseudohypertension in an elderly population. Am J Med 1995; 98: 42-49 doi:10.1016/s0002-9343(99)80079-5
    CrossrefPubMedGoogle Scholar
  • 12 Verdecchia P, Angeli F, Borgioni C. et al. Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Hypertension 2007; 49: 777-783 doi:10.1161/01.Hyp.0000258215.26755.20
    CrossrefPubMedGoogle Scholar
  • 13 Gupta-Malhotra M, Banker A, Shete S. et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens 2014; 28: 73-80
    PubMedGoogle Scholar
  • 14 Borgel J, Springer S, Ghafoor J. et al. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol 2010; 99: 499-506 doi:10.1007/s00392-010-0148-4
    CrossrefPubMedGoogle Scholar
  • 15 Carey RM, Calhoun DA, Bakris GL. et al. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension 2018; 72: e53-e90 doi:10.1161/hyp.0000000000000084
    PubMedGoogle Scholar
  • 16 Charles L, Triscott J, Dobbs B. Secondary Hypertension: Discovering the Underlying Cause. Am Fam Physician 2017; 96: 453-461
    PubMedGoogle Scholar
  • 17 Durán J, Esnaola S, Rubio R. et al. Obstructive sleep apnea–hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163: 685-689
    CrossrefPubMedGoogle Scholar
  • 18 Arar MY, Hogg RJ, Arant Jr. BS. et al. Etiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol 1994; 8: 186-189
    CrossrefPubMedGoogle Scholar
  • 19 Whaley-Connell AT, Sowers JR, Stevens LA. et al. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis 2008; 51: S13-S20 doi:10.1053/j.ajkd.2007.12.016
    CrossrefPubMedGoogle Scholar
  • 20 Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005; 112: 1362-1374 doi:10.1161/circulationaha.104.492348
    CrossrefPubMedGoogle Scholar
  • 21 Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician 2010; 82: 1471-1478
    PubMedGoogle Scholar
  • 22 Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350: 1862-1871 doi:10.1056/NEJMra032393
    CrossrefPubMedGoogle Scholar
  • 23 Rossi GP, Bernini G, Caliumi C. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300 doi:10.1016/j.jacc.2006.07.059
    CrossrefPubMedGoogle Scholar
  • 24 Mulatero P, Stowasser M, Loh KC. et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-1050 doi:10.1210/jc.2003-031337
    CrossrefPubMedGoogle Scholar
  • 25 Funder JW, Carey RM, Fardella C. et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281 doi:10.1210/jc.2008-0104
    CrossrefPubMedGoogle Scholar
  • 26 Erger F. Monogene Formen der arteriellen Hypertonie. Medizinische Genetik 2018; 30: 391-399
    CrossrefGoogle Scholar
  • 27 Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med 1992; 326: 927-932 doi:10.1056/nejm199204023261405
    CrossrefPubMedGoogle Scholar
  • 28 Georgianos PI, Agarwal R. Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nature reviews Nephrology 2016; 12: 636-647 doi:10.1038/nrneph.2016.129
    CrossrefPubMedGoogle Scholar